New article in EP Europace: "Use of a taurolidine containing antimicrobial wash to reduce cardiac implantable electronic device infection"

Logo TauroPace Logo TauroPharm

For professionals

The problem

Infections occur in 1–4 % of all cardiac implantable electronic devices (CIED)​.

The impact

CIED infections lead to a staggering amount of incremental costs.

The solution

TauroPace™ reduces CIED infections without unwanted side effects.

TauroPharm

Newsletter

We'll keep you posted on upcoming events, free download materials, and research insights.

Our website uses cookies and Analytics to guarantee you the best possible user experience. You can find more information in our privacy policy.